Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

2.

Development of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area.

Lugaajju A, Reddy SB, Wahlgren M, Kironde F, Persson KE.

Malar J. 2017 Jan 21;16(1):37. doi: 10.1186/s12936-017-1697-z.

3.

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M; GMZ2 Trial Study Group.

Vaccine. 2016 Aug 31;34(38):4536-4542. doi: 10.1016/j.vaccine.2016.07.041. Epub 2016 Jul 28.

4.

Novel flow cytometry technique for detection of Plasmodium falciparum specific B-cells in humans: increased levels of specific B-cells in ongoing infection.

Lugaajju A, Reddy SB, Rönnberg C, Wahlgren M, Kironde F, Persson KE.

Malar J. 2015 Sep 26;14:370. doi: 10.1186/s12936-015-0911-0.

5.

Frequency of RANTES gene polymorphisms and their association with incidence of malaria: a longitudinal study on children in Iganga district, Uganda.

Lwanira CN, Mukasa MK, Swedberg G, Kironde F.

Malar J. 2015 Sep 5;14:341. doi: 10.1186/s12936-015-0875-0.

6.

Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens.

Reddy SB, Anders RF, Cross N, Mueller I, Senn N, Stanisic DI, Siba PM, Wahlgren M, Kironde F, Beeson JG, Persson KE.

BMC Microbiol. 2015 Jul 3;15:133. doi: 10.1186/s12866-015-0461-1.

7.

Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria.

Kaddumukasa M, Lwanira C, Lugaajju A, Katabira E, Persson KE, Wahlgren M, Kironde F.

PLoS One. 2015 Apr 23;10(4):e0124297. doi: 10.1371/journal.pone.0124297. eCollection 2015.

8.

The impact of vitamin D on the innate immune response to uropathogenic Escherichia coli during pregnancy.

Ramos NL, Sekikubo M, Kironde F, Mirembe F, Sääf M, Brauner A.

Clin Microbiol Infect. 2015 May;21(5):482.e1-7. doi: 10.1016/j.cmi.2014.12.010. Epub 2014 Dec 26.

9.

Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial.

Kaddumukasa M, Buwembo W, Sekikubo M, Naiwumbwe H, Namusoke F, Kiwuwa S, Oketch B, Noor R, Chilengi R, Mworozi E, Kironde F.

BMC Res Notes. 2014 Nov 8;7:793. doi: 10.1186/1756-0500-7-793.

10.

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.

Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TME, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Desai M, Dhorda M, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, Kofoed PE, LeBras J, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Nzila A, Oguike M, Otienoburu SD, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RPM, Zeynudin A, Zongo I, Plowe CV, Sibley CH, Asaq Molecular Marker Study Group.

Am J Trop Med Hyg. 2014 Oct;91(4):833-843. doi: 10.4269/ajtmh.14-0031. Epub 2014 Jul 21. Erratum in: Am J Trop Med Hyg. 2015 May;92(5):1084. Am J Trop Med Hyg. 2019 Mar;100(3):766.

11.
12.

Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.

Ahmed Ismail H, Ribacke U, Reiling L, Normark J, Egwang T, Kironde F, Beeson JG, Wahlgren M, Persson KE.

Clin Vaccine Immunol. 2013 Aug;20(8):1170-80. doi: 10.1128/CVI.00156-13. Epub 2013 Jun 5.

13.

Bioefficacy of long-lasting insecticidal nets against pyrethroid-resistant populations of Anopheles gambiae s.s. from different malaria transmission zones in Uganda.

Okia M, Ndyomugyenyi R, Kirunda J, Byaruhanga A, Adibaku S, Lwamafa DK, Kironde F.

Parasit Vectors. 2013 May 2;6:130. doi: 10.1186/1756-3305-6-130.

14.

Point Mutations in the folP Gene Partly Explain Sulfonamide Resistance of Streptococcus mutans.

Buwembo W, Aery S, Rwenyonyi CM, Swedberg G, Kironde F.

Int J Microbiol. 2013;2013:367021. doi: 10.1155/2013/367021. Epub 2013 Feb 25.

15.

Elevated levels of high-mobility group box-1 (HMGB1) in patients with severe or uncomplicated Plasmodium falciparum malaria.

Angeletti D, Kiwuwa MS, Byarugaba J, Kironde F, Wahlgren M.

Am J Trop Med Hyg. 2013 Apr;88(4):733-5. doi: 10.4269/ajtmh.12-0530. Epub 2013 Feb 11.

16.

Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.

Kiwuwa MS, Byarugaba J, Wahlgren M, Kironde F.

Acta Trop. 2013 Mar;125(3):269-75. doi: 10.1016/j.actatropica.2012.11.013. Epub 2012 Dec 7.

PMID:
23220229
17.
18.

Uropathogenic Escherichia coli isolates from pregnant women in different countries.

Ramos NL, Sekikubo M, Dzung DT, Kosnopfel C, Kironde F, Mirembe F, Brauner A.

J Clin Microbiol. 2012 Nov;50(11):3569-74. doi: 10.1128/JCM.01647-12. Epub 2012 Aug 22.

19.

SCHISTOSOMA MANSONI INFECTION AND THE ASSOCIATED ANTIBODY IMMUNE RESPONSE AMONGST RESIDENTS OF KIGUNGU ENTEBBE, UGANDA.

Odongo-Aginya EI, Wilson RA, Kyabayinze D, Sempewo H, Oliveira RC, Kironde F.

East Afr Med J. 2012 Apr;89(4):111-20.

PMID:
26856035
20.

Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.

Kamugisha E, Jing S, Minde M, Kataraihya J, Kongola G, Kironde F, Swedberg G.

Malar J. 2012 Feb 27;11:58. doi: 10.1186/1475-2875-11-58.

21.

High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.

Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, Berenzon SK, Wahlgren M, Linse S, Persson KE.

PLoS One. 2012;7(2):e32242. doi: 10.1371/journal.pone.0032242. Epub 2012 Feb 21.

22.
23.

Apparent lack of a domestic animal reservoir in Gambiense sleeping sickness in northwest Uganda.

Balyeidhusa AS, Kironde FA, Enyaru JC.

Vet Parasitol. 2012 Jun 8;187(1-2):157-67. doi: 10.1016/j.vetpar.2011.12.005. Epub 2011 Dec 19.

PMID:
22245071
24.

Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?

Kamugisha E, Bujila I, Lahdo M, Pello-Esso S, Minde M, Kongola G, Naiwumbwe H, Kiwuwa S, Kaddumukasa M, Kironde F, Swedberg G.

Acta Trop. 2012 Feb;121(2):148-51. doi: 10.1016/j.actatropica.2011.11.004. Epub 2011 Nov 16.

PMID:
22118982
25.

Effect of acute Plasmodium falciparum malaria on reactivation and shedding of the eight human herpes viruses.

Chêne A, Nylén S, Donati D, Bejarano MT, Kironde F, Wahlgren M, Falk KI.

PLoS One. 2011;6(10):e26266. doi: 10.1371/journal.pone.0026266. Epub 2011 Oct 24.

26.

Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.

Kamugisha E, Sendagire H, Kaddumukasa M, Enweji N, Gheysari F, Swedberg G, Kironde F.

Tanzan J Health Res. 2011 Jan;13(1):40-7.

PMID:
24409646
27.
28.

Malaria burden in pregnancy at mulago national referral hospital in kampala, Uganda.

Namusoke F, Rasti N, Kironde F, Wahlgren M, Mirembe F.

Malar Res Treat. 2010;2010:913857. doi: 10.4061/2010/913857. Epub 2010 Nov 7.

29.

var gene transcription dynamics in Plasmodium falciparum patient isolates.

Blomqvist K, Normark J, Nilsson D, Ribacke U, Orikiriza J, Trillkott P, Byarugaba J, Egwang TG, Kironde F, Andersson B, Wahlgren M.

Mol Biochem Parasitol. 2010 Apr;170(2):74-83. doi: 10.1016/j.molbiopara.2009.12.002. Epub 2009 Dec 16.

PMID:
20006652
30.

Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.

Chene A, Donati D, Orem J, Mbidde ER, Kironde F, Wahlgren M, Bejarano MT.

Semin Cancer Biol. 2009 Dec;19(6):411-20. doi: 10.1016/j.semcancer.2009.10.002. Epub 2009 Nov 6. Review.

PMID:
19897039
31.
32.

Cotrimoxazole resistance of Streptococcus pneumoniae and commensal streptococci from Kampala, Uganda.

Wilén M, Buwembo W, Sendagire H, Kironde F, Swedberg G.

Scand J Infect Dis. 2009;41(2):113-21. doi: 10.1080/00365540802651889.

PMID:
19140088
33.

Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.

Kyabayinze DJ, Karamagi C, Kiggundu M, Kamya MR, Wabwire-Mangen F, Kironde F, Talisuna A.

Afr Health Sci. 2008 Dec;8(4):200-5.

34.

SURFIN4.1, a schizont-merozoite associated protein in the SURFIN family of Plasmodium falciparum.

Mphande FA, Ribacke U, Kaneko O, Kironde F, Winter G, Wahlgren M.

Malar J. 2008 Jul 1;7:116. doi: 10.1186/1475-2875-7-116.

35.

Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.

Boraschi D, Abebe Alemayehu M, Aseffa A, Chiodi F, Chisi J, Del Prete G, Doherty TM, Elhassan I, Engers H, Gyan B, Harandi AM, Kariuki T, Kironde F, Kouriba B, Langhorne J, Laskay T, Medaglini D, Olesen O, Onyebujoh P, Palma C, Sauerwein R, Sibanda E, Steinhoff U, Tagliabue A, Thiel A, Vahedi M, Troye-Blomberg M.

PLoS Negl Trop Dis. 2008 Jun 25;2(6):e255. doi: 10.1371/journal.pntd.0000255.

36.

Default Pathway of var2csa switching and translational repression in Plasmodium falciparum.

Mok BW, Ribacke U, Rasti N, Kironde F, Chen Q, Nilsson P, Wahlgren M.

PLoS One. 2008 Apr 23;3(4):e1982. doi: 10.1371/journal.pone.0001982.

37.

PfEMP1-DBL1alpha amino acid motifs in severe disease states of Plasmodium falciparum malaria.

Normark J, Nilsson D, Ribacke U, Winter G, Moll K, Wheelock CE, Bayarugaba J, Kironde F, Egwang TG, Chen Q, Andersson B, Wahlgren M.

Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15835-40. Epub 2007 Sep 25.

38.

Isolation and genotyping of Toxoplasma gondii from Ugandan chickens reveals frequent multiple infections.

Lindström I, Sundar N, Lindh J, Kironde F, Kabasa JD, Kwok OC, Dubey JP, Smith JE.

Parasitology. 2008 Jan;135(Pt 1):39-45. Epub 2007 Sep 25.

PMID:
17892617
39.

Genome wide gene amplifications and deletions in Plasmodium falciparum.

Ribacke U, Mok BW, Wirta V, Normark J, Lundeberg J, Kironde F, Egwang TG, Nilsson P, Wahlgren M.

Mol Biochem Parasitol. 2007 Sep;155(1):33-44. Epub 2007 May 18.

PMID:
17599553
40.

A molecular link between malaria and Epstein-Barr virus reactivation.

Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.

PLoS Pathog. 2007 Jun;3(6):e80.

41.

A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa.

Maïga O, Djimdé AA, Hubert V, Renard E, Aubouy A, Kironde F, Nsimba B, Koram K, Doumbo OK, Le Bras J, Clain J.

J Infect Dis. 2007 Jul 1;196(1):165-72. Epub 2007 May 24.

PMID:
17538897
42.

Characterization of Maurer's clefts in Plasmodium falciparum-infected erythrocytes.

Haeggström M, VON Euler A, Kironde F, Fernandez V, Wahlgren M.

Am J Trop Med Hyg. 2007 Jan;76(1):27-32.

PMID:
17255224
43.

Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda.

Lindström I, Kaddu-Mulindwa DH, Kironde F, Lindh J.

Acta Trop. 2006 Dec;100(3):218-22. Epub 2006 Dec 8.

PMID:
17157795
44.

Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.

Rasti N, Namusoke F, Chêne A, Chen Q, Staalsoe T, Klinkert MQ, Mirembe F, Kironde F, Wahlgren M.

Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13795-800. Epub 2006 Aug 31.

45.

Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.

Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, Lundkvist A, Wahlgren M, Bejarano MT, Falk KI.

J Infect Dis. 2006 Apr 1;193(7):971-7. Epub 2006 Mar 1.

PMID:
16518759
46.

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.

Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G.

PLoS Med. 2005 Jul;2(7):e190. Epub 2005 Jul 26.

47.

Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.

Sendagire H, Kaddumukasa M, Ndagire D, Aguttu C, Nassejje M, Pettersson M, Swedberg G, Kironde F.

Acta Trop. 2005 Sep;95(3):172-82.

PMID:
16018959
48.

Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.

Sendagire H, Kyabayinze D, Swedberg G, Kironde F.

Trop Med Int Health. 2005 Jun;10(6):537-43.

49.

Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.

Bakyaita N, Dorsey G, Yeka A, Banek K, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Reingold A, Rosenthal PJ, Wabwire-Mangen F.

Am J Trop Med Hyg. 2005 May;72(5):573-80.

PMID:
15891132
50.

Evaluation of quantitative buffy coat (QBC) assay and polymerase chain reaction (PCR) for diagnosis of malaria.

Barman D, Mirdha BR, Samantray JC, Kironde F, Kabra SK, Guleria R.

J Commun Dis. 2003 Sep;35(3):170-81.

PMID:
15796409

Supplemental Content

Loading ...
Support Center